Personalized and genomic medicine hold great promise to improving patient care, preventing disease, and reducing the cost of care, as well as decreasing the cost, size and duration of clinical trials. Significant advancements in these fields are enabling clinicians to tailor medical treatments and preventive strategies specifically to each patient.
The rapid digitization of the health care delivery system, along with increasingly empowered patients who can access and are interested in sharing their health information to promote improvements, helps bring personalized medicine within reach. However, several barriers continue to stand in the way of widespread adoption.
The Bipartisan Policy Center (BPC) brought together health care leaders to engage in a robust policy discussion regarding the information needs of personalized and genomic medicine, the role that health IT plays, the barriers that stand in the way of progress, and the policies needed to address those barriers.
BPC would like to acknowledge Dell Inc. for its support for widespread public access to and engagement in this event through the use of online tools and social media.